Effects of RG7652, a Monoclonal Antibody Against PCSK9, on LDL-C, LDL-C Subfractions, and Inflammatory Biomarkers in Patients at High Risk of or With Established Coronary Heart Disease (from the Phase 2 EQUATOR Study)
Titel:
Effects of RG7652, a Monoclonal Antibody Against PCSK9, on LDL-C, LDL-C Subfractions, and Inflammatory Biomarkers in Patients at High Risk of or With Established Coronary Heart Disease (from the Phase 2 EQUATOR Study)
Auteur:
Baruch, Amos Mosesova, Sofia Davis, John D. Budha, Nageshwar Vilimovskij, Alexandr Kahn, Robert Peng, Kun Cowan, Kyra J. Harris, Laura Pascasio Gelzleichter, Thomas Lehrer, Josh Davis Jr., John C. Tingley, Whittemore G.